Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex

Neuroscience Letters

Volumn 431, Issue 1, 2008, Pages 1-5

  Page, M E ^a   Oropeza, V C ^a   Van Bockstaele, E J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Locus coeruleus; Reverse microdialysis; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; NORADRENALIN; RIMONABANT;

ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; EFFUSION; FRONTAL CORTEX; MALE; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PRIORITY JOURNAL;

ANIMALS; BENZOXAZINES; CANNABINOIDS; DRUG INTERACTIONS; EXTRACELLULAR FLUID; FRONTAL LOBE; MALE; MICRODIALYSIS; MICROINJECTIONS; MORPHOLINES; NAPHTHALENES; NOREPINEPHRINE; PIPERIDINES; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION; TIME FACTORS; UP-REGULATION;

EID: 38049026711     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.11.009     Document Type: Article

References (46)

1. Acquas E., Pisanu A., Marrocu P., and Di Chiara G. Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. Eur. J. Pharmacol. 401 (2000) 179-185
2. Arnold J.C., Topple A.N., Mallet P.E., Hunt G.E., and McGregor I.S. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Res. 921 (2001) 240-255
3. Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J. Psychopharmacol. 11 (1997) 151-162
4. Aston-Jones G. Behavioral functions of locus coeruleus derived from cellular attributes. Physiol. Psychol. 13 (1985) 118-126
5. Aston-Jones G., Foote S.L., and Bloom F.E. Anatomy and physiology of locus coeruleus neurons: functional implications. In: Ziegler M., and Lake C.R. (Eds). Norepinephrine (Frontiers of Clinical Neuroscience) vol. 2 (1984), Williams and Wilkins, Baltimore 92-116
6. Aston-Jones G., Rajkowski J., and Cohen J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog. Brain Res. 126 (2000) 165-182
7. Aston-Jones G., Shaver R., and Dinan T. Cortically projecting nucleus basalis neurons in rat are physiologically heterogeneous. Neurosci. Lett. 46 (1984) 19-24
8. Berrendero F., and Maldonado R. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 163 (2002) 111-117
9. Casswell S., and Marks D. Cannabis induced impairment of performance of a divided attention task. Nature 241 (1973) 60-61
10. Chait L.D., and Pierri J. Effects of smoked marijuana on human performance: a critical review. In: Murphy L., and Bartke A. (Eds). Marijuana/Cannabinoids: Neurobiology and Neurophysiology (1992), CRC Press, Boca Raton, FL 387-423
11. Chaperon F., and Thiebot M.H. Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 13 (1999) 243-281
12. Colombo G., Agabio R., Fa M., Guano L., Lobina C., Loche A., Reali R., and Gessa G.L. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol. 33 (1998) 126-130
13. De Vries T.J., Shaham Y., Homberg J.R., Crombag H., Schuurman K., Dieben J., Vanderschuren L.J., and Schoffelmeer A.N. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 7 (2001) 1151-1154
14. Degenhardt L., Hall W., and Lynskey M. The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Soc. Psychiatry Psychiatr. Epidemiol. 36 (2001) 219-227
15. Devilbiss D.M., Page M.E., and Waterhouse B.D. Locus ceruleus regulates sensory encoding by neurons and networks in waking animals. J. Neurosci. 26 (2006) 9860-9872
16. Egertova M., and Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J. Comp. Neurol. 422 (2000) 159-171
17. Goodwin G.M. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J. Psychopharmacol. 11 (1997) 115-122
18. Herkenham M., Groen B.G., Lynn A.B., De Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res. 552 (1991) 301-310
19. Hoffman A.F., Riegel A.C., and Lupica C.R. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus. Eur. J. Neurosci. 18 (2003) 524-534
20. Hungund B.L., Vinod K.Y., Kassir S.A., Basavarajappa B.S., Yalamanchili R., Cooper T.B., Mann J.J., and Arango V. Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol. Psychiatry 9 (2004) 184-190
21. Jouvet M. Biogenic amines and the states of sleep. Science 163 (1969) 32-41
22. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., and Freund T.F. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21 (2001) 9506-9518
23. Le Moal M., and Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71 (1991) 155-234
24. Lichtman A.H. SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur. J. Pharmacol. 404 (2000) 175-179
25. Manzanares J., Uriguen L., Rubio G., and Palomo T. Role of endocannabinoid system in mental diseases. Neurotox. Res. 6 (2004) 213-224
26. Marsicano G., and Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11 (1999) 4213-4225
27. Mas-Nieto M., Pommier B., Tzavara E.T., Caneparo A., Da Nascimento S., Le Fur G., Roques B.P., and Noble F. Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction. Br. J. Pharmacol. 132 (2001) 1809-1816
28. Meschler J.P., Kraichely D.M., Wilken G.H., and Howlett A.C. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor. Biochem. Pharmacol. 60 (2000) 1315-1323
29. Oropeza V.C., Mackie K., and Van Bockstaele E.J. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res. 1127 (2007) 36-44
30. Oropeza V.C., Page M.E., and Van Bockstaele E.J. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Res. 1046 (2005) 45-54
31. Page M.E., Oropeza V.C., Sparks S.E., Qian Y., Menko A.S., and Van Bockstaele E.J. Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacol. Biochem. Behav. 86 (2007) 162-168
32. Patton G.C., Coffey C., Carlin J.B., Degenhardt L., Lynskey M., and Hall W. Cannabis use and mental health in young people: cohort study. BMJ 325 (2002) 1195-1198
33. Robbins T.W. Cortical noradrenaline, attention and arousal. Psychol. Med. 14 (1984) 13-21
34. Rodriguez J.J., Mackie K., and Pickel V.M. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J. Neurosci. 21 (2001) 823-833
35. Santucci V., Storme J.J., Soubrie P., and Le Fur G. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci. 58 (1996) PL103-PL110
36. Schlicker E., and Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22 (2001) 565-572
37. Solowij N., Michie P.T., and Fox A.M. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol. Psychiatry 37 (1995) 731-739
38. Szabo B., and Schlicker E. Effects of cannabinoids on neurotransmission. Handb. Exp. Pharmacol. (2005) 327-365
39. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 (1997) 2048-2050
40. Troisi A., Pasini A., Saracco M., and Spalletta G. Psychiatric symptoms in male cannabis users not using other illicit drugs. Addiction 93 (1998) 487-492
41. Tzavara E.T., Davis R.J., Perry K.W., Li X., Salhoff C., Bymaster F.P., Witkin J.M., and Nomikos G.G. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br. J. Pharmacol. 138 (2003) 544-553
42. Tzavara E.T., Perry K.W., Rodriguez D.E., Bymaster F.P., and Nomikos G.G. The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus. Eur. J. Pharmacol. 426 (2001) R3-R4
43. Valentino R.J., Foote S.L., and Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann. N.Y. Acad. Sci. 697 (1993) 173-188
44. Vizi E.S., Katona I., and Freund T.F. Evidence for presynaptic cannabinoid CB(1) receptor-mediated inhibition of noradrenaline release in the guinea pig lung. Eur. J. Pharmacol. 431 (2001) 237-244
45. Wade M.R., Tzavara E.T., and Nomikos G.G. Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study. Brain Res. 1005 (2004) 117-123
46. Waterhouse B.D., Sessler F.M., Cheng J.T., Woodward D.J., Azizi S.A., and Moises H.C. New evidence for a gating action of norepinephrine in central neuronal circuits of mammalian brain. Brain Res. Bull. 21 (1988) 425-432